News

High (and low) points in the history of mind sciences can be explored through folklore.

Our Editor in Chief addresses a question from our readers about caffeine.

An interview with Kenneth S. Kendler, MD, vice-chair of the American Psychiatric Association DSM Steering Committee, author of more than 1200 articles, and one of the highest-cited researchers in psychiatry.

What was life like in the 1950s Bronx for a budding preeminent psychiatrist?

In a time of increased telehealth, secure technology is more important than ever.

Two recent papers look at the subtle and surprising links between smoking and pain in different parts of the body.

Brain health disorders cost the global economy more than $3 trillion per year in lost productivity. What can we do about it?

Is this phase 2 trial the end of the road for a potential new treatment?

And Jesus was a sailor when he walked upon the water...

Research on the prevalence of ADHD in Black individuals in the United States highlights the need for future research in this underrepresented group.

As we learn about the effect of COVID-19 on patients with bipolar and other psychiatric disorders, clinicians should be prepared to ask questions to uncover new syndromic behaviors.

A study on a new Alzheimer disease vaccine lacks concrete numbers.

What are best practices for difficult conversations about racism? How can psychiatrists help? The authors present 6 ways to advance discussions about racism in psychiatry.

There is a growing effort to standardize the evaluation and management of pediatric SSRDs, which have been reported as the second most common reason for consultation after suicide assessments.

An award will go to a psychiatrist who exemplifies leadership and goes above and beyond in the areas of clinical practice, educational training and mentorship, and important research

Earn CME Credit by learning more about multiple sclerosis and how it affects patients.

The authors explore the impact of structural racism on psychiatry trainees and the patients they care for (and what can be done about it).

Despite alcohol-related fatalities soaring to the No. 1 cause of death in middle-aged adults, this medication is often overlooked.

Are people with high "neuroticism-depression" likely to drink more than the average person when stressed? We may be getting closer to the answer.

Three new trials suggest a novel antidepressant hides inside the blue-skinned fruit.

Series Editor, Frank A. Clark, MD, introduces the Black History Month series by talking about his greatest mentor when so few were available.

Understanding and developing treatments for the cardiovascular system and how it relates to psychosocial distress and the nervous system are keys to the future of psychiatry.

Is it possible to use cognitive testing, which is brief, easily performed, reliable, and noninvasive, to identify individuals at risk for psychosis?

A rare genetic disorder may have unrecognized psychological consequences.

More than half of physicians believe that seeking psychiatric care would jeopardize their employment. What can be done?

This CME describes current strategies and recent advances in treatment.

Which traditions will keep us afloat during the pandemic, and which ones need to go?

Researchers explored reactivity to a panel of EBV proteins in patients with schizophrenia, thought to be associated with cognitive impairment.

How do men versus women with schizophrenia fare clinically, functionally, and neuropsychologically over the long term?

As physicians first, psychiatrists must consider the big picture, without reflexive and thoughtless prescriptions for psychotropics—even if many, including medical professionals, assume that is all we do.